![Andrew Aromando](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Andrew Aromando
Corporate Officer/Principal chez
ONCOLYTICS BIOTECH INC.
Fortune : 41 490 $ au 31/07/2026
Profil
Andrew P.
Aromando is Chief Business Officer at Oncolytics Biotech, Inc. since 2025.
Mr. Aromando is Chief Operating Officer at Ambrx Biopharma Cayman, Inc. since 2023.
Formerly, Mr. Aromando was SVP-Commercial Development & Operations at Tamir Biotechnology, Inc. Mr. Aromando was Vice President-North American Business Development at Innovex LP from 2000 to 2004.
Mr. Aromando was Chief Operating Officer at Ambrx Biopharma Cayman, Inc. Mr. Aromando was Chief Operating Officer at Ambrx, Inc. from 2023 to 2024.
Mr. Aromando completed undergraduate studies at The College of New Jersey and graduate studies at Rutgers State University of New Jersey.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ONCOLYTICS BIOTECH INC. 0,05 % | 01/06/2026 | 55 100 ( 0,05 % ) | 41 490 $ | 31/07/2026 |
Postes actifs de Andrew Aromando
| Sociétés | Poste | Début |
|---|---|---|
| ONCOLYTICS BIOTECH INC. | Corporate Officer/Principal | 30/06/2025 |
Ambrx Biopharma, Inc.
 Ambrx Biopharma, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biologics company | Directeur des opérations | 28/04/2023 |
Anciens postes connus de Andrew Aromando
| Sociétés | Poste | Fin |
|---|---|---|
Ambrx Biopharma, Inc.
Ambrx Biopharma, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biologics company | Directeur des opérations | 08/03/2024 |
| AMBRX INC | Directeur des opérations | 01/03/2024 |
Innovex LP
 Innovex LP Miscellaneous Commercial ServicesCommercial Services Provides contract product development services | Corporate Officer/Principal | 01/01/2004 |
Tamir Biotechnology, Inc.
 Tamir Biotechnology, Inc. Medical SpecialtiesHealth Technology Engages in discovering and developing new class of therapeutic drugs | Directeur des opérations | - |
Formation de Andrew Aromando
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
29
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Tamir Biotechnology, Inc.
Tamir Biotechnology, Inc. Medical SpecialtiesHealth Technology Engages in discovering and developing new class of therapeutic drugs | Health Technology |
Oncolytics Biotech, Inc.
 Oncolytics Biotech, Inc. BiotechnologyHealth Technology Discovers and develops pharmaceutical products for the treatment of cancers | Health Technology |
Innovex LP
Innovex LP Miscellaneous Commercial ServicesCommercial Services Provides contract product development services | Commercial Services |
The College of New Jersey
 The College of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rutgers State University of New Jersey
 Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ambrx, Inc.
 Ambrx, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
Ambrx Biopharma, Inc.
Ambrx Biopharma, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biologics company | Health Technology |
